Post Categories
Gene Therapy for Ocular Disease
November 8, 2023
Gene therapy for ocular disease is a rapidly evolving field with promise as a treatment option for various genetic and acquired eye diseases. It…
The Buzz on Genetically Modified Mosquitoes vs Malaria
November 6, 2023
Malaria has been a devastating disease throughout history, claiming between 150 to 300 million lives in the 20th century alone. Despite significant progress in…
Messenger RNA Delivery by Lipid Nanoparticles (LNPs)
November 1, 2023
What are they? Lipid nanoparticles (LNPs) are a crucial component in the delivery of RNA drugs, including mRNA-based therapeutics and small interfering RNA (siRNA)…
mRNA Delivery by Viral Vectors
October 25, 2023
What is it? mRNA delivery by viral vectors is a promising approach in the field of gene therapy and vaccine development. Viral vectors are…
Gene Therapy for Alzheimer’s Disease
October 18, 2023
Alzheimer’s disease is a major global health concern: the devastating neurodegenerative disorder is responsible for 60-80 percent of all cases of dementia, and it…
Moderna’s mRNA Flu Vaccine Demonstrates Superiority in Phase III Trial
October 16, 2023
Moderna has announced positive interim results from the Phase III trial of its updated mRNA-1010 influenza vaccine. The company reported that the vaccine met…
Oligonucleotide Therapeutics: Drug-Drug Interactions (DDI)
October 11, 2023
What is it? It is unavoidable for patients to have no other substances in their body when being administered a treatment. Whether it is…
Cryopreservation Breakthrough: Organs Frozen in Time Could Revolutionize Transplant Medicine
October 9, 2023
The notion of suspended animation, often portrayed in science fiction, is based on the idea that bodies can be cryopreserved for a long time…
Gene Therapy for Parkinson’s Disease
October 4, 2023
Parkinson’s disease is a progressive neurodegenerative disorder with no known cure. Current treatment options are limited, aiming to alleviate some symptoms through a combination…
“Truly Stunning” Research Genetically Engineers Virgin Birth in Fruit Flies
October 2, 2023
For the first time, scientists have genetically engineered fruit flies to undergo parthenogenesis, also known as virgin birth or asexual reproduction. The research, published…
What Is a Vector in Gene Therapy?
September 27, 2023
Gene therapy continues to emerge as a promising approach in the treatment and prevention of a wide range of disorders and diseases. Central to…
Examining the Expanding Landscape of Weight Loss Injectables
September 25, 2023
Recent headlines have been abuzz with the groundbreaking weight loss results achieved with the injectable drug semaglutide, demonstrating the potential for people with obesity…
Bispecific Antibody Drug Shows Cancer Treatment Potential
October 7, 2024
A new contender in the fight against lung cancer has emerged, with strong clinical trial results for ivonescimab, a bispecific antibody from partners Akeso…
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
